A Randomized, Double-blinded, Placebo-controlled, Sequential, Single Ascending Dose Evaluation of the Safety and Pharmacokinetics of VBY-376 in Healthy Adults

Trial Profile

A Randomized, Double-blinded, Placebo-controlled, Sequential, Single Ascending Dose Evaluation of the Safety and Pharmacokinetics of VBY-376 in Healthy Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Jan 2014

At a glance

  • Drugs VBY 376 (Primary)
  • Indications Hepatic fibrosis; Hepatitis C
  • Focus Adverse reactions
  • Sponsors Virobay
  • Most Recent Events

    • 31 Jul 2008 Status changed from recruiting to completed (based on information from ClinicalTrials.gov).
    • 22 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top